A detailed history of Shepherd Financial Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Shepherd Financial Partners LLC holds 24,177 shares of ABBV stock, worth $4.01 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
24,177
Previous 23,779 1.67%
Holding current value
$4.01 Million
Previous $3.69 Million 19.46%
% of portfolio
0.58%
Previous 0.53%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $63,608 - $72,475
398 Added 1.67%
24,177 $4.4 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $24,080 - $27,119
175 Added 0.74%
23,779 $3.69 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $123,437 - $142,896
924 Added 4.07%
23,604 $3.52 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $181,803 - $226,242
1,372 Added 6.44%
22,680 $3.06 Million
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $6,652 - $7,660
46 Added 0.22%
21,308 $3.4 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $19,501 - $23,387
-141 Reduced 0.66%
21,262 $3.44 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $51,939 - $59,570
387 Added 1.84%
21,403 $2.87 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $22,707 - $28,868
165 Added 0.79%
21,016 $3.22 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $215,259 - $267,076
-1,631 Reduced 7.25%
20,851 $3.38 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $53,392 - $67,557
497 Added 2.26%
22,482 $3.05 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2,553 - $2,898
24 Added 0.11%
21,985 $2.37 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $45,345 - $50,517
431 Added 2.0%
21,961 $2.47 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $91,047 - $100,231
890 Added 4.31%
21,530 $2.33 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $95,622 - $129,099
1,188 Added 6.11%
20,640 $2.21 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $1.1 Million - $1.29 Million
-12,843 Reduced 39.77%
19,452 $1.7 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $40,793 - $54,588
556 Added 1.75%
32,295 $3.17 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $1.92 Million - $2.91 Million
-29,802 Reduced 48.43%
31,739 $2.42 Million
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $14,281 - $17,869
198 Added 0.32%
61,541 $5.45 Million
Q3 2019

Nov 25, 2019

BUY
$62.98 - $75.72 $1.91 Million - $2.3 Million
30,376 Added 98.09%
61,343 $4.64 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $14,656 - $17,250
-190 Reduced 0.61%
30,967 $2.5 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $83,143 - $102,538
-1,068 Reduced 3.31%
31,157 $2.87 Million
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $51,892 - $61,400
-578 Reduced 1.76%
32,225 $3 Million
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $46,189 - $61,851
502 Added 1.55%
32,803 $3.11 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $144,191 - $158,118
-1,610 Reduced 4.75%
32,301 $3.13 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $2.37 Million - $3.03 Million
33,911
33,911 $3.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Shepherd Financial Partners LLC Portfolio

Follow Shepherd Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Financial Partners LLC with notifications on news.